References
- Bassan A, Steigerwalt R, Keller D, Beilke L, Bradley PM, Bringezu F,
Brock WJ, Burns-Naas LA, Chambers J, Cross K, Dorato M, Elespuru R,
Fuhrer D, Hall F, Hartke J, Jahnke GD, Kluxen FM, McDuffie E, Schmidt
F, Valentin JP, Woolley D, Zane D, Myatt GJ (2024). Developing a
pragmatic consensus procedure supporting the ICH S1B(R1) weight of
evidence carcinogenicity assessment. Front Toxicol. 6:1370045.
- Butler KS, Casey BJ, Garborcauskas GV, Dair BJ, Elespuru RK (2014).
Assessment of
titanium dioxide nanoparticle effects in bacteria: association,
uptake, mutagenicity, co-mutagenicity and DNA repair inhibition.
Mutat Res Genet Toxicol Environ Mutagen. 2014 768:14-22.
- Butler KS, Peeler DJ, Casey BJ, Dair BJ, Elespuru RK (2015).
Silver nanoparticles:
correlating nanoparticle size and cellular uptake with genotoxicity.
Mutagenesis 30:577-91.
- Elespuru RK (1978). Deuterium isotope effects in mutagenesis by
nitroso compounds. Mutat Res. 54:265-70.
- Elespuru RK (1979). Mutagenicity of nitrosocarbaryl and other
methylating nitrosamides as related to uptake in Haemophilus
influenzae. Environ Mutagen.1:249-57.
- Elespuru RK (2011).
Assessment of
heritable genetic effects using new genetic tools and sentinels in an
era of personalized medicine. Environ Mol Mutagen 52:253-63.
- Elespuru RK and Gonda SK (1984). Activation of antitumor agent
gilvocarcins by visible light. Science 223: 69-71.
- Elespuru RK, Hitchins VM (1986).
Wavelength dependence
for the induction of bacteriophage lambda by antitumor agent
gilvocarcin V. Photochem Photobiol 44:607-12.
- Elespuru
R, Lijinsky
W, Setlow
JK (1974). Nitrosocarbaryl as a potent mutagen of environmental
significance. Nature 247:386-7
- Elespuru R, Pfuhler S, Aardema MJ, Chen T, Doak SH, Doherty A,
Farabaugh CS, Kenny J, Manjanatha M, Mahadevan B, Moore MM, Ouédraogo
G, Stankowski LF Jr, Tanir JY (2018).
Genotoxicity
Assessment of Nanomaterials: Recommendations on Best Practices,
Assays, and Methods. Toxicol Sci. 164:391-416.
- Elespuru RK, Sankaranarayanan K (2007).
New approaches to
assessing the effects of mutagenic agents on the integrity of the
human genome. Mutat Res. 616:83-9.
- Elespuru RK, Stupar LL, Gordon JA (1991). Discrimination of mutagenic
intermediates derived from alkylating agents by mutational patterns
generated in Escherichia coli. Carcinogenesis 12:1161-7.
- Elespuru RK, White RJ (1983). Biochemical prophage induction assay: a
rapid test for antitumor agents that interact with DNA. Cancer Res.
43:2819-30.
- Elespuru
RK, Yarmolinsky
MB (1979). A colorimetric assay of lysogenic induction designed for
screening potential carcinogenic and carcinostatic agents.
Environ.mutagen 1:65-78.
- Heflich RH, Bishop ME, Mittelstaedt RA, Yan J, Guerrero SK, Sims AM,
Mitchell K, Moore N, Li X, Mei N, Elespuru RK et al. (2024).
Optimizing the detection of N-nitrosamine mutagenicity in the Ames
test, Reg Tox Pharmacol in press.
- Keefer LK, Lijinsky W, Garcia H (1973).
Deuterium isotope
effect on the carcinogenicity of dimethylnitrosamine in rat liver. J
Natl Cancer Inst. 51:299-302.
- Liao TJ, Crosby L, Cross K, Chen M, Elespuru R (2024).
Medical device report
analyses from MAUDE: Device and patient outcomes, adverse events, and
sex-based differential effects. Regul Toxicol Pharmacol. 149:105591.
- Lijinsky W (1986). Deuterium isotope effects in carcinogenesis by
N-nitroso compounds. J Cancer Res Clin Oncol 112:229-39. [review of
many studies]
- Lijinsky W, Elespuru RK (1976).
Mutagenicity and
carcinogenicity of N-nitroso derivatives of carbamate insecticides.
IARC Sci Publ 14:425-8.
- Lijinsky
W, Schmähl
D (1978). Carcinogenesis by nitroso derivatives of methylcarbamate
insecticides and other nitrosamides in rats and mice. IARC Sci Publ
19:495-501.
- Pfuhler S, Elespuru R, Aardema MJ, Doak SH, Maria Donner E, Honma M,
Kirsch-Volders M, Landsiedel R, Manjanatha M, Singer T, Kim JH (2013).
Genotoxicity of
nanomaterials: refining strategies and tests for hazard
identification. Environ Mol Mutagen 54:229-39.
- Robison TW, Heflich RH, Manjanatha MG, Elespuru R, Atrakchi A, Mei N,
Ding W (2021).
Appropriate in vivo
follow-up assays to an in vitro bacterial reverse mutation (Ames) test
positive investigational drug candidate (active pharmaceutical
ingredient), drug-related metabolite, or drug-related impurity. Mutat
Res Genet Toxicol Environ Mutagen. 868-869:503386.
- Streeter AJ, Nims RW, Anderson LM, Heur YH, von Hofe E, Kleihues P,
Nelson VC, Mico BA, Keefer LK (1990). Single-dose toxicokinetics of
N-nitrosomethylethylamine and N-nitrosomethyl
(2,2,2-trideuterioethyl)amine in the rat. Arch Toxicol 64:109-15.
- Tice RR, Bassan A, Amberg A, Anger LT, Beal MA, Bellion P, Benigni R,
Birmingham J, Brigo A, Bringezu F, Ceriani L, Crooks I, Cross K,
Elespuru R, Faulkner DM, Fortin MC, Fowler P, Frericks M, Gerets HHJ,
Jahnke GD, Jones DR, Kruhlak NL, Lo Piparo E, Lopez-Belmonte J,
Luniwal A, Luu A, Madia F, Manganelli S, Manickam B, Mestres J,
Mihalchik-Burhans AL, Neilson L, Pandiri A, Pavan M, Rider CV, Rooney
JP, Trejo-Martin A, Watanabe-Sailor KH, White AT, Woolley D, Myatt GJ
(2021). In Silico Approaches In Carcinogenicity Hazard
Assessment: Current Status and Future Needs. Comput Toxicol
20:100191.
- Vig S, Gaitan B, Frankle L, Chen Y, Elespuru R, Pfefer T, Huang HC
(2023). Test method
for evaluating the photocytotoxic potential of fluorescence imaging
products. Photochem Photobiol. doi: 10.1111/php.13836.
- von Hofe E, Grahmann F, Keefer LK, Lijinsky W, Nelson V, Kleihues P
(1986). Methylation versus ethylation of DNA in target and nontarget
tissues of Fischer 344 rats treated with N-nitrosomethylethylamine.
Cancer Res 46:1038-42.
- von Hofe E, Schmerold I, Nims RW, Keefer LK, Reist EJ, Kleihues P
(1991). Beta-deuteration of N-nitrosoethylmethylamine causes a shift
in DNA methylation from rat liver to esophagus. Carcinogenesis.
12:545-9.
- Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM,
Cebula TA, Koch WH, Andrews AW, Allen JS, et al. (1991).
DNA deaminating
ability and genotoxicity of nitric oxide and its progenitors.
Science. 254:1001-3.